What weight loss should you expect in your first week on Mounjaro?

The decision you're facing: is this working, or should I be worried?

If you've just had your first Mounjaro injection and stepped on the scales, you're probably trying to answer one of two questions: either 'is this working?' or 'did something go wrong?' The answer to both is almost always the same, it's too early to tell, and here's why that matters.

The 2.5mg starting dose exists to ease your digestive system into treatment. It rarely produces significant appetite suppression on its own. Some people do feel noticeably less hungry from day three or four; others feel almost nothing different. Either is consistent with the medicine working as intended. The prescribers at our clinical team hear this question most weeks, usually from patients who are doing everything right.

What you're actually measuring in week one is a combination of things: any fluid shifts caused by eating less, the weight of food in your gut (which can drop quickly when appetite falls even slightly), and the mood-based calorie changes that often come from committing to a new treatment. Real metabolic change, the kind that shows on a well-calibrated scale week after week, takes longer. That's not a flaw in the medicine. It's biology.

Why some people see a number drop, and others don't

People who report noticeable weight loss in their first week of Mounjaro often attribute it to reduced appetite, but the physiology beneath that is more interesting. Tirzepatide slows gastric emptying, which means food sits in the stomach longer. You feel full sooner and stay fuller longer. If that effect kicks in quickly for you, food intake can drop sharply in the first few days, and the scale reflects it.

Others experience more GI side effects early on (nausea, loose stools, a general feeling of digestive unsettlement) and those side effects can themselves affect the number on the scales. It doesn't mean the medicine is more or less effective for you long-term.

Starting weight matters too. Someone starting at a higher body weight may see a larger absolute number move in week one simply because the baseline is higher, even if the percentage change is similar. A detailed look at whether people typically lose weight in their first week on Mounjaro is worth reading alongside this page if you want the fuller picture.

One practical thing: if you've just started, keep your pen in the fridge door where you'll see it and remember your weekly injection day. Consistency of timing matters more than the first week's number.

What first-week Mounjaro weight loss actually predicts

Very little, as it happens. Research on GLP-1 and dual agonist treatments consistently shows that early response is a poor predictor of long-term outcome. The SURMOUNT-1 trial (2,539 adults, 72 weeks) saw average weight reductions of around 20–21% at the highest dose, but those results accumulated gradually across a full titration schedule, not from a flying start at 2.5mg. NICE's appraisal of tirzepatide (TA1026) describes the evidence base and the criteria under which the medicine is recommended.

If you've had your first week and the scale hasn't moved, the evidence suggests you should continue rather than conclude the medicine isn't for you. The clinical review for a dose increase (when that point comes) is the right moment to assess progress. Context on what the first month of Mounjaro looks like can help you set realistic expectations for the weeks ahead. And if you're specifically concerned about not losing weight in your first week on Mounjaro, that page addresses the common reasons directly.

Cost is a reasonable thing to think about at this stage too. Eli Lilly's UK price changes in 2025 shifted the private market, and understanding what you're paying for (and why) is part of making a decision you'll stick with. See our treatment page for what's currently available.

When to raise a concern with your prescriber

There are situations where your first week does warrant a call. If nausea is so severe you can't eat or drink normally, if you're vomiting repeatedly, or if you experience sharp abdominal pain that radiates toward your back, contact your prescriber or GP promptly. The MHRA's guidance specifically flags acute pancreatitis as a known, rare side effect of GLP-1 medicines that needs urgent assessment if symptoms match. Anything that feels like more than ordinary GI discomfort deserves clinical input.

For most people, though, the first week is simply the start of a longer process. How long Mounjaro takes to work for meaningful weight reduction is a question with a more reassuring answer than week one might suggest, and understanding the timeline after each individual injection can help you read your body's signals more accurately going forward.

If you haven't started yet and want a prescriber to review whether Mounjaro is suitable for you, you're welcome to speak to our prescribers through a free consultation.